Herpes Simplex Virus Infection
📧 Sign up to get email alerts when something new happens for Herpes Simplex Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
This clinical trial studies the natural history of severe viral infections and characterizes immune defects in patients without known immuno…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Neonatal Phase 1 Valacyclovir Study [Phase 1]
This clinical trial update reports the completed Phase 1 neonatal study of valacyclovir for herpes simplex infection, sponsored by NIAID.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Zoster Vaccine to Enhance Protection Against Zoster in Solid-organ Transplantation [Phase 2]
A Phase 2 clinical trial evaluating a zoster vaccine to enhance protection against herpes zoster in solid-organ transplant recipients, with …
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects [Phase 3]
Phase 3 trial evaluating pritelivir for acyclovir-resistant mucocutaneous herpes simplex virus infections in immunocompromised subjects has …
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL [Phase 3]
Phase 3 trial evaluating acyclovir in ventilated patients with pneumonia and HSV-1 detected in BAL is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Evaluating Benzoyl Peroxide for Preventing Recurrence of HSV-1 Outbreaks With Rescue Crossover Option [Phase 2]
Phase 2 clinical trial evaluating benzoyl peroxide for preventing recurrence of herpes simplex virus type 1 outbreaks, with a rescue crossov…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
The update describes a pharmacokinetics study of intravenous acyclovir in pediatric oncology patients (recruiting).
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2
Expanded-access intermediate-size treatment protocol for pritelivir to treat immunocompromised patients with treatment-resistant herpes simp…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections. [Phase 4]
Phase 4 randomized, placebo-controlled, double-blind study of 2LHERP for orofacial herpes infections is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy Volunteers [Phase 1]
Phase I trial update describes safety, tolerability, and pharmacokinetics of a single IM-250 dose in healthy volunteers for herpes simplex v…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Phase III Study of ASP2151 in Herpes Simplex Patients [Phase 3]
Phase III trial of ASP2151 for herpes simplex infection has completed, with results posted on 2024-10-09.
-
FDA approval · 2024-09-27FDA Approved: PENCICLOVIR — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved the original application (ANDA) for penciclovir topical cream (generic) from Padagis Israel Pharmaceuticals Ltd. for the treatm…
-
FDA approval · 2024-01-08FDA Approved: ACYCLOVIR — Original Application (Slate Run Pharmaceuticals, LLC)
The FDA approved the original ANDA for acyclovir from Slate Run Pharmaceuticals, LLC, authorizing a generic acyclovir product. This marks re…
-
FDA approval · 2023-11-21FDA Approved: ACYCLOVIR — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved the original application for acyclovir by Alembic Pharmaceuticals Inc., making a generic version of the antiviral available.
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir [Phase 1]
Phase 1 trial investigating how esomeprazole affects the pharmacokinetics of pritelivir in HSV infection.
-
FDA approval · 2023-05-08FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for Valacyclovir hydrochloride from Aurobindo Pharma Limited. The approval confirms continued market…
-
FDA approval · 2023-03-09FDA Approved: ACYCLOVIR SUSPENSION — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved ACYCLOVIR SUSPENSION under Original Application for a generic acyclovir suspension by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2022-08-18FDA Approved: ACYCLOVIR — Original Application (Advagen Pharma Limited)
FDA approves the original ANDA for acyclovir from Advagen Pharma Limited.
-
FDA approval · 2022-07-01FDA Approved: ACYCLOVIR — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original ANDA for generic acyclovir, enabling brand-generic competition for this antiviral. The approva…
-
FDA approval · 2022-05-03FDA Approved: DOCOSANOL — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the Original Application for docosanol from Alembic Pharmaceuticals Limited.
-
FDA approval · 2021-11-15FDA Approved: ACYCLOVIR — Original Application (Solco Healthcare US, LLC)
FDA approved the original application for acyclovir from Solco Healthcare US, LLC (oral generic).
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1) [Phase 1]
A Phase 1 trial assessing immune response and general immune health in subjects infected with HSV-1 has completed with results posted in 202…
-
FDA approval · 2021-07-16FDA Approved: AVACLYR — Supplemental Application (Fera Pharmaceuticals, LLC)
The FDA approved a supplemental application for AVACLYR (acyclovir) from Fera Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2020-12-07Clinical Trial Update: Palatability Testing of a New Paediatric Formulation of Valacyclovir [Phase 4]
Phase 4 trial evaluating palatability of a new paediatric formulation of valacyclovir; completed.
-
FDA approval · 2020-11-09FDA Approved: ACYCLOVIR — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's original application for acyclovir, a generic antiviral product for infections caused by herpes simplex virus and vari…